Jim Simons Electro Core, Inc. Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.21 - $5.63 $3,654 - $97,962	17,400 Added 6.7%	277,060 $71,000
Q3 2022 Nov 14, 2022	SELL	$0.46 - $6.75 $1,466 - $21,519	-3,188 Reduced 1.21%	259,660 $105,000
Q2 2022 Aug 12, 2022	BUY	$0.27 - $0.61 $35,868 - $81,037	132,848 Added 102.19%	262,848 $134,000
Q1 2022 May 13, 2022	SELL	$0.5 - $0.88 $53,800 - $94,688	-107,600 Reduced 45.29%	130,000 $76,000
Q4 2021 Feb 11, 2022	SELL	$0.58 - $1.09 $46,045 - $86,532	-79,388 Reduced 25.04%	237,600 $138,000
Q3 2021 Nov 12, 2021	BUY	$0.93 - $1.18 $32,166 - $40,813	34,588 Added 12.25%	316,988 $358,000
Q2 2021 Aug 13, 2021	BUY	$1.19 - $2.06 $75,324 - $130,393	63,298 Added 28.89%	282,400 $336,000
Q1 2021 May 13, 2021	BUY	$1.62 - $3.05 $177,555 - $334,286	109,602 Added 100.09%	219,102 $451,000
Q4 2020 Feb 10, 2021	BUY	$1.44 - $1.98 $157,680 - $216,810	109,500 New	109,500 $171,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $705M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.